How to Buy National Research Stock
National Research Corp
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada.
National Research stock last closed at $16.04, up 0.06% from the previous day, and has decreased 36.48% in one year. It has overperformed other stocks in the Health Information Services industry by 0.29 percentage points. National Research stock is currently +64.43% from its 52-week low of $9.76, and -40.75% from its 52-week high of $27.07.
There are currently 22.79M shares of NRC outstanding. The market capitalization of NRC is $365.48M. In the last 24 hours, 103,000 NRC shares were traded.
How to Buy National Research Stock
Not sure how to invest in National Research stock? Here's how.
- Decide where to buy National Research stock: You need to choose a stock brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you determine where to buy National Research stock.
- Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Deposit money your brokerage account: Choose your payment method and add your info.
- Evaluate National Research stock: The National Research ticker symbol is NRC. Is National Research stock a good investment? Should you buy shares of NRC? How do NRC's underlying business fundamentals look? Do top analysts think National Research is a good buy? Why has NRC's stock price moved recently? (Hint: Our stock research website can help you evaluate if NRC is a good stock to buy).
- Place your NRC buy order: Decide if you will purchase NRC shares at the current market price or use a limit order to purchase NRC stock at a specific price.
- Get notifications regarding your NRC position: Create a watchlist to important notifications about your investment in National Research stock.
Step 1: Decide where to buy National Research stock
You need a brokerage account to access the NASDAQ market and buy NRC stock.
Our recommended brokerage: eToro
In our opinion, eToro is the best place to buy stocks. Here's why:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to world markets: From Tech to Healthcare, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've picked the right brokerage, the next step is to fill out some personal info so you can invest in NRC today.
How to Open a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to open a new trading account.
- Submit your data by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you have filled out your info on our top ranked stock app, you can securely and quickly fund your account:
Watch this video walkthrough for more details transferring funds into your brokerage account.
Step 4: Evaluate National Research stock
After you have identified the best place to buy National Research stock, it's important to analyze their stock prior to buying, so you can wrap your head around the risk and opportunity.
National Research stock at a glance
National Research Due Diligence Checks
WallStreetZen was built to help average investors perform more accurate fundamental analysis.
You can see all of the due diligence checks on NRC's stock page.
Is NRC stock overvalued?
Investors use many financial metrics, analyses, models, and charts to gauge NRC's true value.
Using relative valuations metrics:
- NRC could be undervalued based on its P/E ratio of 15.42x, relative to Health Information Services industry P/E ratio of 45.89x
- NRC may be overvalued based on its P/B ratio of 12.32x, relative to Health Information Services industry P/B ratio of 3.87x
You can access more valuation research on NRC's stock here.
NRC Financial Health Overview
Positive Financial Indicators:
- NRC earnings of $35.11M is not enough to cover its interest payments.
- NRC's operating cash flow of $29.23M allows it to safely service it's debt of $65.21M.
Negative Financial Indicators:
- NRC has a relatively high debt to equity ratio of 3.56.
- NRC profit margin has gone down from 20.6% to 17.1% in the past year.
- Total NRC debt is higher than 5 years ago, relative to shareholder equity.
- There are more long-term liabilities than short-term assets on the NRC balance sheet.
- There are more short-term liabilities than short-term assets on the NRC balance sheet.
NRC Trading Indicators
NRC Earnings
Last year, NRC earnings were $24.21M. In the last five year, NRC's earnings have grown by -6.43% per year. This was slower than the Health Information Services industry average of 14.72%.
Last year, NRC revenue was $141.30M. Over the past 5 year, NRC's revenue has grown by 1.62% per year. This was slower than the Health Information Services industry average of 15.3%.
Find out more about NRC's earnings and revenue performance here.
Who is buying/selling NRC?
Over the past 12 months, insiders at NRC have bought more shares than they have sold.
Patrick E. Beans, 10% Owner of NRC, was the latest NRC insider to buy. They bought $33,972.50 worth of NRC stock on May 12, 2025.
Dig into more about who owns NRC shares here.
Does NRC stock generate passive income?
National Research pays a dividend of 2.24%, compared to the Health Information Services industry's average dividend yield of 2.47%. If you owned $1,000 of NRC stock, you would have received $22.44 in the past 12 months.
National Research dividend payments have not consistently grown over the past decade and have not remained stable.
Get more info about National Research dividend yield and history here.
NRC Social Trading Data
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Place your NRC buy order
You have two main types of orders:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are generally the best for newer investors. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at a given price, place a limit order.
Click the Open button and your broker will place your order.
If you want more info about buying stocks on eToro, watch the helpful video below:
Step 6: Get notifications regarding your NRC position
Now that you own some shares in NRC, you'll want to stay up-to-date on your company.
Create a watchlist to track the most important metrics related to your NRC stock.
NRC Feed
How to Buy Stock in National Research
To reiterate, here are the 6 steps for buying National Research stock:
- Decide where to buy National Research stock
- Create your brokerage account
- Deposit money your brokerage account
- Evaluate National Research stock
- Place your NRC buy order
- Get notifications regarding your NRC position
If you are looking for a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you want to get notifications regarding your investment in National Research, create your watchlist below.
Related Stock Buying Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.